Skip to main content
NCBI home page
Biophysical Journal logoLink to Biophysical Journal
. 2002 Dec;83(6):3470–3481. doi: 10.1016/S0006-3495(02)75346-0

Equilibrium and kinetic studies of the interactions of a porphyrin with low-density lipoproteins.

Stéphanie Bonneau 1, Christine Vever-Bizet 1, Patrice Morlière 1, Jean-Claude Mazière 1, Daniel Brault 1
PMCID: PMC1302421  PMID: 12496113

Abstract

Low-density lipoproteins (LDL) play a key role in the delivery of photosensitizers to tumor cells in photodynamic therapy. The interaction of deuteroporphyrin, an amphiphilic porphyrin, with LDL is examined at equilibrium and the kinetics of association/dissociation are determined by stopped-flow. Changes in apoprotein and porphyrin fluorescence suggest two classes of bound porphyrins. The first class, characterized by tryptophan fluorescence quenching, involves four well-defined sites. The affinity constant per site is 8.75 x 10(7) M(-1) (cumulative affinity 3.5 x 10(8) M(-1)). The second class corresponds to the incorporation of up to 50 molecules into the outer lipidic layer of LDL with an affinity constant of 2 x 10(8) M(-1). Stopped-flow experiments involving direct LDL porphyrin mixing or porphyrin transfer from preloaded LDL to albumin provide kinetic characterization of the two classes. The rate constants for dissociation of the first and second classes are 5.8 and 15 s(-1); the association rate constants are 5 x 10(8) M(-1) s(-1) per site and 3 x 10(9) M(-1) s(-1), respectively. Both fluorescence and kinetic analysis indicate that the first class involves regions at the boundary between lipids and the apoprotein. The kinetics of porphyrin-LDL interactions indicates that changes in the distribution of photosensitizers among various carriers could be very sensitive to the specific tumor microenvironment.

Full Text

The Full Text of this article is available as a PDF (564.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andrade Suzana M., Costa Sílvia M. B. Spectroscopic studies on the interaction of a water soluble porphyrin and two drug carrier proteins. Biophys J. 2002 Mar;82(3):1607–1619. doi: 10.1016/S0006-3495(02)75512-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Beltramini M., Firey P. A., Ricchelli F., Rodgers M. A., Jori G. Steady-state and time-resolved spectroscopic studies on the hematoporphyrin-lipoprotein complex. Biochemistry. 1987 Oct 20;26(21):6852–6858. doi: 10.1021/bi00395a040. [DOI] [PubMed] [Google Scholar]
  3. Biade S., Mazière J. C., Mora L., Santus R., Mazière C., Auclair M., Morlière P., Dubertret L. Lovastatin potentiates the photocytotoxic effect of photofrin II delivered to HT29 human colonic adenocarcinoma cells by low density lipoprotein. Photochem Photobiol. 1993 Feb;57(2):371–375. doi: 10.1111/j.1751-1097.1993.tb02303.x. [DOI] [PubMed] [Google Scholar]
  4. Boyle R. W., Dolphin D. Structure and biodistribution relationships of photodynamic sensitizers. Photochem Photobiol. 1996 Sep;64(3):469–485. doi: 10.1111/j.1751-1097.1996.tb03093.x. [DOI] [PubMed] [Google Scholar]
  5. Brault D., Vever-Bizet C., Le Doan T. Spectrofluorimetric study of porphyrin incorporation into membrane models--evidence for pH effects. Biochim Biophys Acta. 1986 May 28;857(2):238–250. doi: 10.1016/0005-2736(86)90352-4. [DOI] [PubMed] [Google Scholar]
  6. Brown M. S., Goldstein J. L. Receptor-mediated control of cholesterol metabolism. Science. 1976 Jan 16;191(4223):150–154. doi: 10.1126/science.174194. [DOI] [PubMed] [Google Scholar]
  7. Candide C., Morlière P., Mazière J. C., Goldstein S., Santus R., Dubertret L., Reyftmann J. P., Polonovski J. In vitro interaction of the photoactive anticancer porphyrin derivative photofrin II with low density lipoprotein, and its delivery to cultured human fibroblasts. FEBS Lett. 1986 Oct 20;207(1):133–138. doi: 10.1016/0014-5793(86)80026-6. [DOI] [PubMed] [Google Scholar]
  8. Carr A. C., Myzak M. C., Stocker R., McCall M. R., Frei B. Myeloperoxidase binds to low-density lipoprotein: potential implications for atherosclerosis. FEBS Lett. 2000 Dec 29;487(2):176–180. doi: 10.1016/s0014-5793(00)02227-4. [DOI] [PubMed] [Google Scholar]
  9. Cunderlíková B., Kongshaug M., Gangeskar L., Moan J. Increased binding of chlorin e6 to lipoproteins at low pH values. Int J Biochem Cell Biol. 2000 Jul;32(7):759–768. doi: 10.1016/s1357-2725(00)00015-7. [DOI] [PubMed] [Google Scholar]
  10. Dougherty T. J., Gomer C. J., Henderson B. W., Jori G., Kessel D., Korbelik M., Moan J., Peng Q. Photodynamic therapy. J Natl Cancer Inst. 1998 Jun 17;90(12):889–905. doi: 10.1093/jnci/90.12.889. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Gal D., MacDonald P. C., Porter J. C., Simpson E. R. Cholesterol metabolism in cancer cells in monolayer culture. III. Low-density lipoprotein metabolism. Int J Cancer. 1981 Sep 15;28(3):315–319. doi: 10.1002/ijc.2910280310. [DOI] [PubMed] [Google Scholar]
  12. Galántai R., Bárdos-Nagy I., Módos K., Kardos J., Závodszky P., Fidy J. Serum albumin-lipid membrane interaction influencing the uptake of porphyrins. Arch Biochem Biophys. 2000 Jan 1;373(1):261–270. doi: 10.1006/abbi.1999.1522. [DOI] [PubMed] [Google Scholar]
  13. HAVEL R. J., EDER H. A., BRAGDON J. H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest. 1955 Sep;34(9):1345–1353. doi: 10.1172/JCI103182. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Halfman C. J., Nishida T. Method for measuring the binding of small molecules to proteins from binding-induced alterations of physical-chemical properties. Biochemistry. 1972 Aug 29;11(18):3493–3498. doi: 10.1021/bi00768a025. [DOI] [PubMed] [Google Scholar]
  15. Henderson B. W., Bellnier D. A., Greco W. R., Sharma A., Pandey R. K., Vaughan L. A., Weishaupt K. R., Dougherty T. J. An in vivo quantitative structure-activity relationship for a congeneric series of pyropheophorbide derivatives as photosensitizers for photodynamic therapy. Cancer Res. 1997 Sep 15;57(18):4000–4007. [PubMed] [Google Scholar]
  16. Ho C. H., Britt D. W., Hlady V. Human low density lipoprotein and human serum albumin adsorption onto model surfaces studied by total internal reflection fluorescence and scanning force microscopy. J Mol Recognit. 1996 Sep-Dec;9(5-6):444–455. doi: 10.1002/(sici)1099-1352(199634/12)9:5/6<444::aid-jmr281>3.0.co;2-i. [DOI] [PubMed] [Google Scholar]
  17. Jain R. K. Transport of molecules in the tumor interstitium: a review. Cancer Res. 1987 Jun 15;47(12):3039–3051. [PubMed] [Google Scholar]
  18. Jori G., Beltramini M., Reddi E., Salvato B., Pagnan A., Ziron L., Tomio L., Tsanov T. Evidence for a major role of plasma lipoproteins as hematoporphyrin carriers in vivo. Cancer Lett. 1984 Oct;24(3):291–297. doi: 10.1016/0304-3835(84)90025-9. [DOI] [PubMed] [Google Scholar]
  19. Kessel D. Porphyrin-lipoprotein association as a factor in porphyrin localization. Cancer Lett. 1986 Nov;33(2):183–188. doi: 10.1016/0304-3835(86)90023-6. [DOI] [PubMed] [Google Scholar]
  20. Kuzelová K., Brault D. Kinetic and equilibrium studies of porphyrin interactions with unilamellar lipidic vesicles. Biochemistry. 1994 Aug 16;33(32):9447–9459. doi: 10.1021/bi00198a010. [DOI] [PubMed] [Google Scholar]
  21. Lavi Adina, Weitman Hana, Holmes Robert T., Smith Kevin M., Ehrenberg Benjamin. The depth of porphyrin in a membrane and the membrane's physical properties affect the photosensitizing efficiency. Biophys J. 2002 Apr;82(4):2101–2110. doi: 10.1016/S0006-3495(02)75557-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Lee D. M., Alaupovic P. Physiocochemical properties of low-density lipoproteins of normal human plasma. Evidence for the occurrence of lipoprotein B in associated and free forms. Biochem J. 1974 Feb;137(2):155–167. doi: 10.1042/bj1370155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Luna M. C., Ferrario A., Rucker N., Gomer C. J. Decreased expression and function of alpha-2 macroglobulin receptor/low density lipoprotein receptor-related protein in photodynamic therapy-resistant mouse tumor cells. Cancer Res. 1995 May 1;55(9):1820–1823. [PubMed] [Google Scholar]
  24. Maman N., Brault D. Kinetics of the interactions of a dicarboxylic porphyrin with unilamellar lipidic vesicles: interplay between bilayer thickness and pH in rate control. Biochim Biophys Acta. 1998 Nov 11;1414(1-2):31–42. doi: 10.1016/s0005-2736(98)00149-7. [DOI] [PubMed] [Google Scholar]
  25. Mazière J. C., Morlière P., Santus R. The role of the low density lipoprotein receptor pathway in the delivery of lipophilic photosensitizers in the photodynamic therapy of tumours. J Photochem Photobiol B. 1991 Mar;8(4):351–360. doi: 10.1016/1011-1344(91)80111-t. [DOI] [PubMed] [Google Scholar]
  26. Miller J. W., Walsh A. W., Kramer M., Hasan T., Michaud N., Flotte T. J., Haimovici R., Gragoudas E. S. Photodynamic therapy of experimental choroidal neovascularization using lipoprotein-delivered benzoporphyrin. Arch Ophthalmol. 1995 Jun;113(6):810–818. doi: 10.1001/archopht.1995.01100060136048. [DOI] [PubMed] [Google Scholar]
  27. Moan J., Rimington C., Western A. The binding of dihematoporphyrin ether (photofrin II) to human serum albumin. Clin Chim Acta. 1985 Feb 15;145(3):227–236. doi: 10.1016/0009-8981(85)90028-2. [DOI] [PubMed] [Google Scholar]
  28. Pass H. I. Photodynamic therapy in oncology: mechanisms and clinical use. J Natl Cancer Inst. 1993 Mar 17;85(6):443–456. doi: 10.1093/jnci/85.6.443. [DOI] [PubMed] [Google Scholar]
  29. Peterson G. L. A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal Biochem. 1977 Dec;83(2):346–356. doi: 10.1016/0003-2697(77)90043-4. [DOI] [PubMed] [Google Scholar]
  30. Rensen P. C., de Vrueh R. L., Kuiper J., Bijsterbosch M. K., Biessen E. A., van Berkel T. J. Recombinant lipoproteins: lipoprotein-like lipid particles for drug targeting. Adv Drug Deliv Rev. 2001 Apr 25;47(2-3):251–276. doi: 10.1016/s0169-409x(01)00109-0. [DOI] [PubMed] [Google Scholar]
  31. Reyftmann J. P., Morliere P., Goldstein S., Satus R., Dubertret L., Lagrange D. Interaction of human serum low density lipoproteins with porphyrins: a spectroscopic and photochemical study. Photochem Photobiol. 1984 Dec;40(6):721–729. doi: 10.1111/j.1751-1097.1984.tb04643.x. [DOI] [PubMed] [Google Scholar]
  32. Rudling M. J., Collins V. P., Peterson C. O. Delivery of aclacinomycin A to human glioma cells in vitro by the low-density lipoprotein pathway. Cancer Res. 1983 Oct;43(10):4600–4605. [PubMed] [Google Scholar]
  33. Schmidt-Erfurth U., Diddens H., Birngruber R., Hasan T. Photodynamic targeting of human retinoblastoma cells using covalent low-density lipoprotein conjugates. Br J Cancer. 1997;75(1):54–61. doi: 10.1038/bjc.1997.9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Schumaker V. N., Phillips M. L., Chatterton J. E. Apolipoprotein B and low-density lipoprotein structure: implications for biosynthesis of triglyceride-rich lipoproteins. Adv Protein Chem. 1994;45:205–248. doi: 10.1016/s0065-3233(08)60641-5. [DOI] [PubMed] [Google Scholar]
  35. Segrest J. P., Jones M. K., De Loof H., Dashti N. Structure of apolipoprotein B-100 in low density lipoproteins. J Lipid Res. 2001 Sep;42(9):1346–1367. [PubMed] [Google Scholar]
  36. Shaw J. M., Shaw K. V., Yanovich S., Iwanik M., Futch W. S., Rosowsky A., Schook L. B. Delivery of lipophilic drugs using lipoproteins. Ann N Y Acad Sci. 1987;507:252–271. doi: 10.1111/j.1749-6632.1987.tb45806.x. [DOI] [PubMed] [Google Scholar]
  37. Vever-Bizet C., Brault D. Kinetics of incorporation of porphyrins into small unilamellar vesicles. Biochim Biophys Acta. 1993 Dec 12;1153(2):170–174. doi: 10.1016/0005-2736(93)90402-l. [DOI] [PubMed] [Google Scholar]
  38. Vitols S., Peterson C., Larsson O., Holm P., Aberg B. Elevated uptake of low density lipoproteins by human lung cancer tissue in vivo. Cancer Res. 1992 Nov 15;52(22):6244–6247. [PubMed] [Google Scholar]
  39. Yang C. Y., Chen S. H., Gianturco S. H., Bradley W. A., Sparrow J. T., Tanimura M., Li W. H., Sparrow D. A., DeLoof H., Rosseneu M. Sequence, structure, receptor-binding domains and internal repeats of human apolipoprotein B-100. Nature. 1986 Oct 23;323(6090):738–742. doi: 10.1038/323738a0. [DOI] [PubMed] [Google Scholar]
  40. de Smidt P. C., Versluis A. J., van Berkel T. J. Properties of incorporation, redistribution, and integrity of porphyrin-low-density lipoprotein complexes. Biochemistry. 1993 Mar 23;32(11):2916–2922. doi: 10.1021/bi00062a023. [DOI] [PubMed] [Google Scholar]
  41. de Vries H. E., Moor A. C., Dubbelman T. M., van Berkel T. J., Kuiper J. Oxidized low-density lipoprotein as a delivery system for photosensitizers: implications for photodynamic therapy of atherosclerosis. J Pharmacol Exp Ther. 1999 Apr;289(1):528–534. [PubMed] [Google Scholar]

Articles from Biophysical Journal are provided here courtesy of The Biophysical Society

RESOURCES